JPH0138089B2 - - Google Patents

Info

Publication number
JPH0138089B2
JPH0138089B2 JP55079043A JP7904380A JPH0138089B2 JP H0138089 B2 JPH0138089 B2 JP H0138089B2 JP 55079043 A JP55079043 A JP 55079043A JP 7904380 A JP7904380 A JP 7904380A JP H0138089 B2 JPH0138089 B2 JP H0138089B2
Authority
JP
Japan
Prior art keywords
piperazine
compound
methoxyphenyl
hydrochloride
reference example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55079043A
Other languages
English (en)
Japanese (ja)
Other versions
JPS574921A (en
Inventor
Hiroyuki Nagano
Michiro Takagi
Noboru Kubodera
Isao Matsunaga
Tamotsu Yamazaki
Hiroyuki Nahata
Kazunari Sakai
Shunichi Hata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP7904380A priority Critical patent/JPS574921A/ja
Priority to US06/272,077 priority patent/US4438115A/en
Priority to ZA813937A priority patent/ZA813937B/xx
Priority to KR1019810002129A priority patent/KR850000215B1/ko
Priority to EP81104560A priority patent/EP0042162B1/en
Priority to AT81104560T priority patent/ATE5372T1/de
Priority to CA000379686A priority patent/CA1166158A/en
Priority to AR285707A priority patent/AR229471A1/es
Priority to DE8181104560T priority patent/DE3161490D1/de
Publication of JPS574921A publication Critical patent/JPS574921A/ja
Publication of JPH0138089B2 publication Critical patent/JPH0138089B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7904380A 1980-06-13 1980-06-13 Remedy for cardiovascular disorder Granted JPS574921A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP7904380A JPS574921A (en) 1980-06-13 1980-06-13 Remedy for cardiovascular disorder
US06/272,077 US4438115A (en) 1980-06-13 1981-06-10 Compositions and methods for treating diseases in circulatory organs
ZA813937A ZA813937B (en) 1980-06-13 1981-06-11 Agents for treating diseases in circulatory organs
KR1019810002129A KR850000215B1 (ko) 1980-06-13 1981-06-12 페닐 피페라진 유도체의 제조방법
EP81104560A EP0042162B1 (en) 1980-06-13 1981-06-12 Compositions for treating diseases in circulatory organs
AT81104560T ATE5372T1 (de) 1980-06-13 1981-06-12 Zusammensetzungen fuer die behandlung von krankheiten der kreislauforgane.
CA000379686A CA1166158A (en) 1980-06-13 1981-06-12 Agents for treating diseases in circulatory organs
AR285707A AR229471A1 (es) 1980-06-13 1981-06-12 Procedimiento de preparacion de un derivado de alcoxi-carbonilhexil-metoxifenil piperazina
DE8181104560T DE3161490D1 (en) 1980-06-13 1981-06-12 Compositions for treating diseases in circulatory organs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7904380A JPS574921A (en) 1980-06-13 1980-06-13 Remedy for cardiovascular disorder

Publications (2)

Publication Number Publication Date
JPS574921A JPS574921A (en) 1982-01-11
JPH0138089B2 true JPH0138089B2 (en, 2012) 1989-08-11

Family

ID=13678875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7904380A Granted JPS574921A (en) 1980-06-13 1980-06-13 Remedy for cardiovascular disorder

Country Status (9)

Country Link
US (1) US4438115A (en, 2012)
EP (1) EP0042162B1 (en, 2012)
JP (1) JPS574921A (en, 2012)
KR (1) KR850000215B1 (en, 2012)
AR (1) AR229471A1 (en, 2012)
AT (1) ATE5372T1 (en, 2012)
CA (1) CA1166158A (en, 2012)
DE (1) DE3161490D1 (en, 2012)
ZA (1) ZA813937B (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397855A (en) * 1981-06-26 1983-08-09 Warner-Lambert Company 4-(Substituted)-α, α-dimethyl-1-piperazine pentanoic acids and derivatives as anti-arteriosclerotic agents and method
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH048416Y2 (en, 2012) * 1985-10-15 1992-03-03
GB2271930B (en) * 1992-11-03 1996-07-24 Wyeth John & Brother Ltd Pharmaceutical piperazine derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH354084A (fr) * 1955-06-29 1961-05-15 Parke Davis & Co Procédé de préparation de pipérazines
US2922788A (en) 1958-05-26 1960-01-26 Parke Davis & Co Phenylpiperazine compounds and process for producing the same
BE662455A (en, 2012) * 1964-04-14
FR2326923A1 (fr) * 1975-10-08 1977-05-06 Bouchara Emile Derives du bis(piperazinyl-1)-1,2 ethane
DE2555290A1 (de) * 1975-12-09 1977-06-16 Boehringer Mannheim Gmbh Neue benzopyron-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS574921A (en) 1982-01-11
DE3161490D1 (en) 1983-12-29
EP0042162A3 (en) 1982-03-10
EP0042162A2 (en) 1981-12-23
CA1166158A (en) 1984-04-24
AR229471A1 (es) 1983-08-31
US4438115A (en) 1984-03-20
ATE5372T1 (de) 1983-12-15
EP0042162B1 (en) 1983-11-23
KR830006257A (ko) 1983-09-20
ZA813937B (en) 1982-07-28
KR850000215B1 (ko) 1985-03-06

Similar Documents

Publication Publication Date Title
WO1999020620A1 (fr) Derive d'isoquinoleine et medicament
JPH04230681A (ja) １，４‐ベンゾチアゼピン誘導体
JPH0531523B2 (en, 2012)
EP0350012A2 (en) Antiviral composition
JP2650038B2 (ja) ピロリチジン化合物およびその用途
EP0104614B1 (en) Phenylpiperazine derivatives and process for producing the same
JP3093419B2 (ja) １，４‐ベンゾチアゼピン誘導体
JPH0138089B2 (en, 2012)
DK168441B1 (da) [R-(E)]-4-(3-phosphono-2-propenyl)-2-piperazincarboxylsyre, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende forbindelsen samt anvendelse heraf
WO1994005290A1 (en) Platelet aggregation inhibitor
CN114349745B (zh) 一种用于治疗心肌缺血的药物及其制备方法
US4923863A (en) Morpholine derivatives, pharmaceutical compositions and use
JPS6219405B2 (en, 2012)
JPH03157378A (ja) １，５―ベンゾチアゼピン誘導体、その製法及びその合成中間体
JPH0667892B2 (ja) アシルアミノアルカノイル化合物
JP2000501409A (ja) ５―ナフタレン―１―イル―１，３―ジオキサン誘導体、その製造およびその治療上の用途
EP0342577B1 (en) Use of dihydropyridine derivatives for the prophylaxis or treatment of cerebral circulation disorders
JP2000103736A (ja) 血管透過性亢進抑制剤
JPH0153245B2 (en, 2012)
US5441962A (en) Method for treating hyperlipemia
JPH05503510A (ja) 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
JP2756740B2 (ja) ２−シクロヘキセノン化合物及び該化合物を有効成分とする脳機能改善薬
JP2989059B2 (ja) 置換アニリド
JP4011780B2 (ja) ジヒドロキノリン誘導体
JPH0511112B2 (en, 2012)